We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$778M
AUM Growth
-$1.85M
Cap. Flow
-$35.3M
Cap. Flow %
-4.54%
Top 10 Hldgs %
34.42%
Holding
5,522
New
920
Increased
1,531
Reduced
1,579
Closed
1,330

Sector Composition

Rank Sector Weight
1 Industrials 6%
2 Financials 5.45%
3 Technology 5.24%
4 Consumer Discretionary 4.75%
5 Healthcare 3.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBTM
4701
JBT Marel
JBTM
$6.38B
-200
Closed -$6K
QVCGB
4702
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
-5
Closed -$6K
JOYY
4703
JOYY Inc
JOYY
$3.77B
-806
Closed -$62K
TVRD
4704
Tvardi Therapeutics
TVRD
$18.2M
-102
Closed -$68K
BCPC
4705
Balchem Corp
BCPC
$5.56B
-267
Closed -$14K
SPLP
4706
DELISTED
STEEL PARTNERS HOLDINGS L.P.
SPLP
-200
Closed -$3K
FFNW
4707
DELISTED
First Financial Northwest, Inc
FFNW
-300
Closed -$3K
LGTY
4708
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
-2,288
Closed -$23K
TBNK
4709
DELISTED
Territorial Bancorp Inc.
TBNK
$0 ﹤0.01%
23
-1,047
-98% -$21.6K
CUTR
4710
DELISTED
Cutera, Inc.
CUTR
$0 ﹤0.01%
26
+11
+73% +$112
ROIC
4711
DELISTED
Retail Opportunity Investments Corp.
ROIC
-7,906
Closed -$118K
RVNC
4712
DELISTED
Revance Therapeutics, Inc.
RVNC
-1,400
Closed -$44K
CDMO
4713
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-1,853
Closed -$24K
VIRX
4714
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-5
Closed -$5.8K
IQDE
4715
DELISTED
FlexShares International Quality Dividend Defensive Index Fund
IQDE
-82
Closed -$2K
LUMO
4716
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
-33
Closed -$9K
ENSV
4717
DELISTED
Enservco Corp.
ENSV
$0 ﹤0.01%
+6
New +$225
CHUY
4718
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
-95
Closed -$4K
TELL
4719
DELISTED
Tellurian Inc.
TELL
$0 ﹤0.01%
+2
New +$31
EGRX
4720
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-610
Closed -$8K
FSD
4721
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
-225
Closed -$4K
WIRE
4722
DELISTED
Encore Wire Corp
WIRE
-282
Closed -$14K
CVLY
4723
DELISTED
Codorus Valley Bancorp Inc
CVLY
-362
Closed -$6K
CTHR
4724
DELISTED
Charles & Colvard Ltd
CTHR
-44
Closed -$1K
CEM
4725
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
-1
Closed

Similar funds

Tower Research Capital (TRC)'s Q2 2014 Portfolio in Review

As of Q2 2014, Tower Research Capital (TRC) held 5,522 positions worth $778M, down 0.24% from $780M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $35.3M in Q2 2014, closing 1,330 positions and reducing 1,579 holdings. Its most notable exit was iShares Core S&P Small-Cap ETF, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 6% of assets, up from 5.1% a quarter earlier, followed by Financials and Technology.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $9.03M.

  • Tower Research Capital (TRC)'s largest Q2 2014 buy was iShares Russell 1000 Value ETF: 89,185 shares worth $9.03M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2014, an estimated $177M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2014 reduction was Invesco QQQ Trust, cutting an estimated $110M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Small-Cap ETF in Q2 2014, selling an estimated $10.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $778M portfolio in Q2 2014.
  • Tower Research Capital (TRC) opened 920 new positions and closed 1,330 in Q2 2014.
  • Tower Research Capital (TRC)'s portfolio value fell 0.24% quarter-over-quarter to $778M.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2014, filed 14 Aug 2014.